TD
Tobii Dynavox AB (publ)
TDVXF · OTC
$6.65 -11.33% (-$0.85)
1M -1.96%
Market Cap 6.94B kr
P/E Ratio 30.75x
Div. Yield 0.81%
ROE 35.95%
Bulios Fair Price
$9.13
37.3% upside
Trenutna cena
$6.65
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TDVXF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
38 /100
Fair PEG 3.05x
P/E 30.75x
P/B 9.72x
Growth
100 /100
Growing Book val. growth 42.00%
EPS growth 50.24%
Rev. growth 26.58%
Profitability
67 /100
Strong Op. margin 12.80%
Gross margin 68.95%
FCF margin 9.84%
Quality
82 /100
Excellent ROA 8.60%
ROIC 12.86%
Asset turnover 0.97x
Debt
63 /100
Moderate Int. coverage 9.81x
Debt/Equity 1.55x
Net debt/EBITDA 1.76x
Stability
81 /100
Stable EPS volatility 51.43%
Beta 0.81x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TDVXF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Fredrik Ruben
Employees
1,063
Headquarters
Stockholm
Prihajajoči dogodki
21 OKT.
Earnings
Upcoming earnings report